Personen

Dr. med. Alexander Häge

Tel.: 0621 1703-4503, -4541

Fax: 0621 1703-4545

E-Mail

Therapiegebäude, 1. OG, Raum 129

 

Studienkoordination

Ruth Berg, E-Mail, Tel.: 0621 1703-4541
Therapiegebäude, 1. OG, Raum 146

Publikationen

Publikationen in peer-reviewed Zeitschriften seit 2006

TOP 5 Publikationen:

  1. Man KKC, Coghill D, Chan EW, Lau WCY, Hollis C, Liddle E, Banaschewski T, McCarthy S, Neubert A, Sayal K, Ip P, Schuemie MJ, Sturkenboom MCJM, Sonuga-Barke E, Buitelaar J, Carucci S, Zuddas A, Kovshoff H, Garas P, Nagy P, Inglis SK, Konrad K, Häge A, Rosenthal E, Wong IC. Association of Risk of Suicide Attempts With Methylphenidate Treatment. JAMA Psychiatry. 2017 74(10):1048-1055. Epub 2017 Jul 26.
  2. Häge A, Alm B, Banaschewski T, Becker K, Colla M, Freitag C, Geissler J, von Gontard A, Graf E, Haack-Dees B, Hänig S, Hennighausen K, Hohmann S, Jacob C, Jaite C, Jennen-Steinmetz C, Kappel V, Matthies S, Philipsen A, Poustka L, Retz W, Rösler M, Schneider-Momm K, Sobanski E, Vloet TD, Warnke A, Jans T. Does the efficacy of parent-child training depend on maternal symptom improvement? Results from a randomized controlled trial on children and mothers both affected by attention-deficit/hyperactivity disorder (ADHD). Eur Child Adolesc Psychiatry. 2018 Jan 23. [Epub ahead of print].
  3. Nagy P, Häge A, Coghill DR, Caballero B, Adeyi B, Anderson CS, Sikirica V, Cardo E. Functional outcomes from a head-to-head, randomized, double-blind trial of lisdexamfetamine dimesylate and atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder and an inadequate response to methylphenidate. Eur Child Adolesc Psychiatry. 2016 25(2):141-9. Epub 2015 May 22.
  4. Inglis SK, Carucci S, Garas P, Häge A, Banaschewski T, Buitelaar JK, Dittmann RW, Falissard B, Hollis C, Kovshoff H, Liddle E, McCarthy S, Nagy P, Neubert A, Rosenthal E, Sonuga-Barke E, Wong I, Zuddas A, Coghill DC, ADDUCE Consortium . Prospective observational study protocol to investigate long-term adverse effects of methylphenidate in children and adolescents with ADHD: the Attention Deficit Hyperactivity Disorder Drugs Use Chronic Effects (ADDUCE) study. BMJ Open. 2016 6(4):e010433.
  5. Bliznak L, Berg R, Häge A, Dittmann RW. High rate of non-eligibility: methodological factors impacting on recruitment for a multicentre, double-blind study of paediatric patients with major depressive disorder. Pharmacopsychiatry. 2013 46(1):23-8.